@WHO: @DrTedros @HSarkkinen "One of the strengths of the Solidarity PLUS trial is that it is a truly global study, with researchers all over the world participating"-@DrTedros #COVID19 https://t.co/K6tk22NnFf

http://twitter.com/WHO
via IFTTT